No carcinogenicity was noted at doses of 400 mg/ kg/ day in mice and 600 mg/ kg/ day in rats, corresponding to exposures ~ 39 and 168 times the expected human exposure, respectively, suggesting an insignificant carcinogenic potential of stavudine in clinical therapy.